PofoliaShared via Pofolia

American Journal of Neuroradiology· 2026Q1

Incidence and Predictors of Braid Deformations following Aneurysm Treatment with the DERIVO(2heal) Flow Diverter: A Single-Center Experience

Luca Meucci, Lukas Meyer, Gregor Peter, Helge Kniep et al.

Short summary

Braid deformations (BDs) occurred in 12.9% of intracranial aneurysm treatments using DERIVO or DERIVO2heal flow diverters, with younger patient age and incomplete postprocedural wall apposition identified as key predictors.

AI-generated from the title and abstract; the full text is not read.

Abstract

BACKGROUND AND PURPOSE: Flow diverters (FDs) are established endoluminal devices for intracranial aneurysm treatment. Concerns have been raised regarding braid deformations (BDs) affecting braid stability. We investigated the incidence and potential predictors of BDs in DERIVO and DERIVO2heal FDs. MATERIALS AND METHODS: This retrospective single-center observational study included consecutive patients undergoing intracranial aneurysm treatment with a DERIVO or DERIVO2heal FD between 2016 and 2025. BDs were assessed applying recently proposed ESMINT endorsed classification guidelines. Clinical outcomes, aneurysm occlusion, and in-stent stenosis (ISS) were assessed. Multivariable logistic regression analysis was performed to identify independent predictors of BDs. RESULTS: A total of 147 procedures treating 189 aneurysms were included. BDs occurred in 19/147 procedures (12.9%), with no significant difference between the DERIVO (13.8%) and DERIVO2heal (11.9%; p=0.75). Most BDs (24/28 [85.7%]) were detected at 6-months follow-up. Fish-mouthing and braid hump were the most frequent categories, detected in 8/147 (5.4%) devices. Younger patient age (aOR=0.95, 95% CI 0.91–0.99; p=0.01) and incomplete postprocedural wall apposition (aOR=11.12, 95% CI 2.67–49.30; p<0.01) were independent predictors of BDs. Moreover, BDs were significantly associated with higher rates of ISS (BDs vs non-BDs, 89.5% vs 13.3%, p=<0.01). Aneurysm occlusion rates (p=0.95) and ischemic complications at 6 months (p=0.70) did not differ between patients with and without BDs. CONCLUSION: BDs occurred in 13% of patients, without significant difference between the two device generations. Younger patient age and incomplete wall apposition after deployment seem to negatively affect short–term device stability. No negative impact on clinical outcome and occlusion rates was detected.

The authors' abstract, as published at the source. American Journal of Neuroradiology, 2026 · DOI ↗

TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Sign in on the web to open

Field: Neurology (Medicine)

NeurologyMedicine